Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bazelet Oglesby is a joint venture between the Israeli medical cannabis leader Bazelet Group and the American plant science specialist Oglesby Plants International. The company focuses on the development, genetic stabilization, and mass production of medical-grade cannabis through advanced tissue culture technologies. By leveraging Oglesby's expertise in plant physiology and Bazelet's clinical knowledge of cannabinoid profiles, the entity provides standardized, pathogen-free starting materials for the global pharmaceutical and medical cannabis industries. Their operations ensure chemical consistency across crops, which is critical for clinical research and the formulation of precise cannabinoid-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bazelet Oglesby.